Myopia progression: Can we control it?

John R Phillips, Loertscher Martin, Nicola ANSTICE

Research output: Contribution to journalReview article

Abstract

Many more children suffer from myopia than was the case 50 years ago: in parts of Asia, over 70% of children are now myopic and require some form of refractive correction to see clearly. A vast literature on possible causes of myopia and methods for controlling myopia progression has built up over the years and, until recently, distinguishing between hypothesis and real evidence has posed a significant challenge. Recent clinical trials of a variety of methods for controlling myopia progression have shown encouraging results and several methods are becoming commercially available. This article addresses the question: should we now be attempting to control myopia progression in a clinical setting? If so, what are the options?
Original languageEnglish
Pages (from-to)33-44
Number of pages12
JournalOptometry in Practice
Volume14
Issue number1
Publication statusPublished - 2013
Externally publishedYes

Fingerprint

Myopia
Clinical Trials

Cite this

Phillips, J. R., Martin, L., & ANSTICE, N. (2013). Myopia progression: Can we control it? Optometry in Practice, 14(1), 33-44.
Phillips, John R ; Martin, Loertscher ; ANSTICE, Nicola. / Myopia progression: Can we control it?. In: Optometry in Practice. 2013 ; Vol. 14, No. 1. pp. 33-44.
@article{db0472cf2b724605b7cc43acfc006c4c,
title = "Myopia progression: Can we control it?",
abstract = "Many more children suffer from myopia than was the case 50 years ago: in parts of Asia, over 70{\%} of children are now myopic and require some form of refractive correction to see clearly. A vast literature on possible causes of myopia and methods for controlling myopia progression has built up over the years and, until recently, distinguishing between hypothesis and real evidence has posed a significant challenge. Recent clinical trials of a variety of methods for controlling myopia progression have shown encouraging results and several methods are becoming commercially available. This article addresses the question: should we now be attempting to control myopia progression in a clinical setting? If so, what are the options?",
author = "Phillips, {John R} and Loertscher Martin and Nicola ANSTICE",
year = "2013",
language = "English",
volume = "14",
pages = "33--44",
journal = "Optometry in Practice",
issn = "1467-9051",
publisher = "Distance Learning Ltd.",
number = "1",

}

Phillips, JR, Martin, L & ANSTICE, N 2013, 'Myopia progression: Can we control it?', Optometry in Practice, vol. 14, no. 1, pp. 33-44.

Myopia progression: Can we control it? / Phillips, John R; Martin, Loertscher; ANSTICE, Nicola.

In: Optometry in Practice, Vol. 14, No. 1, 2013, p. 33-44.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Myopia progression: Can we control it?

AU - Phillips, John R

AU - Martin, Loertscher

AU - ANSTICE, Nicola

PY - 2013

Y1 - 2013

N2 - Many more children suffer from myopia than was the case 50 years ago: in parts of Asia, over 70% of children are now myopic and require some form of refractive correction to see clearly. A vast literature on possible causes of myopia and methods for controlling myopia progression has built up over the years and, until recently, distinguishing between hypothesis and real evidence has posed a significant challenge. Recent clinical trials of a variety of methods for controlling myopia progression have shown encouraging results and several methods are becoming commercially available. This article addresses the question: should we now be attempting to control myopia progression in a clinical setting? If so, what are the options?

AB - Many more children suffer from myopia than was the case 50 years ago: in parts of Asia, over 70% of children are now myopic and require some form of refractive correction to see clearly. A vast literature on possible causes of myopia and methods for controlling myopia progression has built up over the years and, until recently, distinguishing between hypothesis and real evidence has posed a significant challenge. Recent clinical trials of a variety of methods for controlling myopia progression have shown encouraging results and several methods are becoming commercially available. This article addresses the question: should we now be attempting to control myopia progression in a clinical setting? If so, what are the options?

M3 - Review article

VL - 14

SP - 33

EP - 44

JO - Optometry in Practice

JF - Optometry in Practice

SN - 1467-9051

IS - 1

ER -